Asia
Bukwang Pharmaceutical Returns to Profit in Q1
Bukwang Pharmaceutical (KRX:003000) posted first-quarter net income attributable to shareholders of 1.2 billion won, reversing the attributable net loss of 69 million won a year earlier, according to a Tuesday filing with the Korea Exchange.Sales of the South Korean pharmaceutical company were down 0.1% year over year to 47.8 billion won.Shares of Bukwang Pharmaceutical fell nearly 7% at market close.
KRX:003000
